Antisense Oligonucleotide Blockade of Tumor Necrosis Factor-α in Two Murine Models of Colitis

Kathleen Myers(Ionis Pharmaceuticals (United States)), Sreekant Murthy, Anne Flanigan, Donna Witchell, Madeline Butler, Susan Murray, Andrew Siwkowski, Deborah Goodfellow, Karen Madsen, Brenda F. Baker

Journal of Pharmacology and Experimental Therapeutics

January 1, 2003

10.1124/jpet.102.040329

Cited by 90

Abstract

Related Papers

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

Isao Okayasu, Shigeru Hatakeyama, Masahiro Yamada et al.|Gastroenterology|1990|2.4k

Clinicopathologic study of dextran sulfate sodium experimental acute colitis

Kazuko Shichijo, Mutsumi Matuu, Yuji Ikeda et al.|The Japanese Journal of Pharmacology|1998|1.9k

Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

Fiona Powrie, Michael W. Leach, Smita Mauze et al.|Immunity|1994|1.1k

Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.

Susan Chan, B Perussia, Jean Gupta et al.|The Journal of Experimental Medicine|1991|986

Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice

Levinus A. Dieleman, Ben U. Ridwan, Gary S. Tennyson et al.|Gastroenterology|1994|676